Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Simoes

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Antimicrobial Agents and Chemotherapy|March 1, 1995
Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulinJ R Groothuis, E A Simoes, M V Lehr, et al.
The Journal of Pediatrics|July 1, 1994
Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trialW J Rodriguez, C B Hall, R Welliver, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 4, 1999
Clinical practice guidelines for the management of chronic sinusitis in childrenK H Chan, C P Winslow, M J Levin, et al.
The New England Journal of Medicine|November 18, 1993
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study GroupJ R Groothuis, E A Simoes, M J Levin, et al.
Pediatrics|March 1, 1997
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study GroupW J Rodriguez, W C Gruber, R C Welliver, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1999
Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV diseaseH C Meissner, J R Groothuis, W J Rodriguez, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Antimicrobial Agents and Chemotherapy|March 1, 1995
Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulinJ R Groothuis, E A Simoes, M V Lehr, et al.
The Journal of Pediatrics|July 1, 1994
Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trialW J Rodriguez, C B Hall, R Welliver, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 4, 1999
Clinical practice guidelines for the management of chronic sinusitis in childrenK H Chan, C P Winslow, M J Levin, et al.
The New England Journal of Medicine|November 18, 1993
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study GroupJ R Groothuis, E A Simoes, M J Levin, et al.
Pediatrics|March 1, 1997
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study GroupW J Rodriguez, W C Gruber, R C Welliver, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1999
Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV diseaseH C Meissner, J R Groothuis, W J Rodriguez, et al.
Pageof 4